Lung transplantation for lymphangioleiomyomatosis

被引:53
作者
Pechet, TT
Meyers, BF
Guthrie, TJ
Battafarano, RJ
Trulock, EP
Cooper, JD
Patterson, GA
机构
[1] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA
关键词
D O I
10.1016/S1053-2498(03)00195-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Lymphangioleiomyomatosis is a rare disease in women leading to respiratory failure. We describe a single-institution experience with lung transplantation for end-stage lymphangioleiomyomatosis. Methods: We retrospectively reviewed records of patients transplanted for lymphangioleiomyomatosis between 1989 and 2001. Follow-up was-complete on all patients (median 3.5 years). Results: Seven single and 7 bilateral transplants were performed on 14 recipients (mean age 41.8 years). Eleven patients suffered the following intra-operative complications: dysrhythmia (1); blood loss > 1,000 ml (7); extensive pleural adhesions (10); hypothermia (1); phrenic nerve injury (1); and graft dysfunction (2). The following post-operative complications occurred in 11 recipients: dysrhythmia (7); respiratory failure (5); sepsis (3); airway dehiscence (2); vocal cord dysfunction (1); cholecystitis (1); deep vein thrombosis (1); acute renal failure (1); and pericarditis (1). Postoperative chylous fistulas necessitated thoracic duct ligation (1); sclerosis (6); and drainage of ascites (1). There were no peri-operative deaths. Late deaths occurred due to sepsis in 2 patients and obliterative bronchiolitis in 1 patient. Survival rates were 100%, 90% and 69% at (1, 2 and 5 years, respectively.) Mean FEV1 (1.77 +/- 1.06 vs 0.60 +/- 0.91) and 6-minute walk (1,519 +/- 379 vs 826 +/- 293 feet) improved at 1 year as compared with pre-transplant evaluation. Five patients reached criteria for bronchiolitis obliterans syndrome. One recipient has had a documented recurrence of lymphangioleiomyomatosis in the transplanted lung. Conclusions: Early and late survival after lung transplant are comparable in lymphangioleiomyomatosis patients versus patients with other diseases. Morbidity is common after transplant for lymphangioleiomyomatosis and is usually due to lymphangioleiomyomatosis-related complications. Lymph angioleiomyomatosis recurrence in the allograft does not pose a substantial clinical problem.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 19 条
[1]   Lymphangioleiomyomatosis:: Recurrence after single lung transplantation [J].
Bittmann, I ;
Dose, TB ;
Müller, C ;
Dienemann, H .
HUMAN PATHOLOGY, 1997, 28 (12) :1420-1423
[2]   Lung transplantation for lymphangioleiomyomatosis [J].
Boehler, A ;
Speich, R ;
Russi, EW ;
Weder, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (17) :1275-1280
[3]   Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis [J].
Chu, SC ;
Horiba, K ;
Usuki, J ;
Avila, NA ;
Chen, CC ;
Travis, WD ;
Ferrand, VJ ;
Moss, J .
CHEST, 1999, 115 (04) :1041-1052
[4]   Lung transplantation for lymphangioleiomyomatosis:: Role of imaging in the assessment of complications related to the underlying disease [J].
Collins, J ;
Müller, NL ;
Kazerooni, EA ;
McAdams, HP ;
Leung, AN ;
Love, RB .
RADIOLOGY, 1999, 210 (02) :325-332
[5]  
COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713
[6]   Lymphangioleiomyomatosis - The pathophysiology of diminished exercise capacity [J].
Crausman, RS ;
Jennings, CA ;
Irvin, CG ;
King, TE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (04) :1368-1376
[7]  
ESTENNE M, 1984, LANCET, V1, P275
[9]   PULMONARY LYMPHANGIOLEIOMYOMATOSIS - A REPORT OF 46 PATIENTS INCLUDING A CLINICOPATHOLOGICAL STUDY OF PROGNOSTIC FACTORS [J].
KITAICHI, M ;
NISHIMURA, K ;
ITOH, H ;
IZUMI, T .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (02) :527-533
[10]  
MEYERS B, 1999, OPIN TECHNOL THORAC, V4, P162